Does ketamine mimic aspects of schizophrenic speech?

Area of Science:

• Neuroscience
• Psychiatry
• Computational Linguistics

Background:

• Speech disturbances are key diagnostic symptoms of schizophrenia.
• N-methyl-D-aspartate (NMDA) receptor antagonist ketamine can mimic schizophrenia symptoms.
• Investigating ketamine's effect on speech may elucidate NMDA system involvement in schizophrenia.

Purpose of the Study:

• To determine if ketamine administration and schizophrenia diagnosis alter speech patterns.
• To analyze speech for repetitiousness, idea density, and verb density using quantitative methods.

Main Methods:

• Two experiments were conducted: a within-subjects study (ketamine vs. placebo in healthy volunteers) and a between-groups study (schizophrenia patients vs. healthy controls).
• Computer-aided analysis of speech samples assessed repetitiousness, idea density, and verb density.

Main Results:

• Speech repetitiousness significantly increased in both schizophrenia patients and ketamine-treated volunteers, confirming the primary hypothesis.
• Idea density did not significantly change in either group.
• Verb density significantly decreased in the ketamine group, suggesting a specific cognitive impairment.

Conclusions:

• Increased speech repetitiousness is a shared feature between schizophrenia and ketamine-induced states, supporting the NMDA hypothesis of schizophrenia.
• Reduced verb density with ketamine may indicate a specific type of cognitive impairment requiring further investigation in psychosis.